Introduction: Shoulder pain and disability ipsilateral to the implant site is a common complication of cardiac rhythm device implantation, yet very little has been published about this morbidity.
Australian-based medtech company Convergence Medical has secured $5 million in series A funding from U.S. investor Avicella Capital. The company claims it has developed a world-first arthroscopic ...